Moreover, MMP2, MMP9, MMP12, and MMP16-enriched KEGG pathways include “Bladder cancer, endocrine resistance, and relaxin signaling pathway”, etc., (Fig. 8D). The gene discussed is MMP2; the disease is urinary bladder carcinoma.